Physician profile
Gavish Patel
NPI 1821080078
$9,990.87
in general payments reported to CMS, 2019-2025
14 companies · $1,357 in 2025
The $1,357 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,543 · 2020: $477 · 2021: $222 · 2022: $548 · 2023: $988 · 2024: $1,857 · 2025: $1,357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,201.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,580.73 | 2019-2024 | |
| W. L. Gore & Associates, INC. | $1,923.33 | 2024-2025 | Gore Viabahn Endoprosthesis With Heparin, Gore Excluder Aaa Endoprosthesis, Gore Propaten Vascular Graft |
| Davol INC. | $968.97 | 2019-2025 | Phasix Mesh |
| Ethicon US, LLC | $720.05 | 2019-2023 | N/A, Enseal X1, Harmonic |
| Silk Road Medical, INC. | $586.57 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Shockwave Medical, INC | $216.02 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $215.06 | 2023-2024 | Heli-Fx Endoanchor System, Endurant Iis |
| Janssen Pharmaceuticals, INC | $214.51 | 2019-2022 | |
| Smith+Nephew, INC. | $175.89 | 2020-2025 | Grafix Pl, Stravix Pl |
| Tela Bio, INC. | $132.14 | 2024 | Ovitex 2s |
| Conmed Corporation | $124.42 | 2024 | Conmed Hemostasis |
| Polynovo North America LLC | $119.44 | 2025 | Novosorb Btm |
| Janssen Biotech, INC. | $13.74 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gavish Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.